Lista de obras -

A phase I study of irinotecan in combination with metronomic temozolomide in patients with recurrent glioblastoma

artículo científico publicado en 2014

A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma.

artículo científico publicado en 2015

ATCT-05OBJECTIVE RESPONSE (OR) TO NEOADJUVANT TREATMENT IN GLIOBLASTOMA AND ITS IMPACT ON OVERALL SURVIVAL (OS). A META-ANALYSIS OF NEOADJUVANT TRIALS OF THE SPANISH GROUP FOR RESEARCH IN NEUROONCOLOGY (GEINO).

artículo científico publicado en 2015

Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial.

artículo científico publicado en 2016

Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO).

artículo científico publicado en 2012

Circulating Endothelial Cells and Microparticles as Prognostic Markers in Advanced Non-Small Cell Lung Cancer ⬇️

artículo científico publicado el 15 de octubre de 2012

Circulating endothelial and endothelial progenitor cells in non-small-cell lung cancer.

artículo científico publicado en 2010

Circulating endothelial cells and procoagulant microparticles in patients with glioblastoma: prognostic value.

artículo científico publicado en 2013

Correction to: SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).

artículo científico publicado en 2017

Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients.

artículo científico publicado en 2018

Efficacy and tolerability of lacosamide for secondary epileptic seizures in patients with brain tumor: A multicenter, observational retrospective study

artículo científico publicado en 2017

Erratum: Efficacy and tolerability of lacosamide for secondary epileptic seizures in patients with brain tumor: A multicenter, observational retrospective study.

artículo científico publicado en 2017

Extended-schedule dose-dense temozolomide in refractory gliomas

artículo científico publicado en 2009

Extragonadal germ cell tumors: prognostic factors and long-term follow-up

artículo científico publicado en 1995

Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib

artículo científico publicado en 2017

Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients

artículo científico publicado en 2016

Long-term results of neoadjuvant chemotherapy and combined chemoradiotherapy before surgery in the management of locally advanced oesophageal cancer: a single-centre experience.

artículo científico publicado en 2009

Neoadjuvant cisplatin and etoposide, with or without tamoxifen, prior to radiotherapy in high-grade gliomas: a single-center experience.

artículo científico publicado en 2005

P17.04RANO CRITERIA APPLIED TO A PHASE II RANDOMIZED, MULTICENTER TRIAL COMPARING TEMOZOLOMIDE (TMZ) VS TMZ-PLUS-BEVACIZUMAB (BEV) BEFORE STANDARD TREATMENT IN UNRESECTABLE GLIOBLASTOMA (GBM) PATIENTS (P).GENOM 009 STUDY BY THE GEINO GROUP.

artículo científico publicado en 2014

P18.08A MULTICENTRIC, OBSERVATIONAL, NON INTERVENTIONAL STUDY OF EFFICACY AND SAFETY OF LACOSAMIDE FOR THE TREATMENT OF EPILEPTIC SEIZURES IN PATIENTS WITH BRAIN TUMORS.

artículo científico publicado en 2014

Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification

artículo científico publicado en 2017

Phase II trial of irinotecan and metronomic temozolomide in patients with recurrent glioblastoma.

artículo científico publicado en 2015

Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 patients

artículo científico publicado en 1997

Primitive neuroectodermal kidney tumor

artículo científico publicado en 2002

Radium-223 international early access program: results from the Spanish subset.

artículo científico publicado en 2017

Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with renal cell carcinoma

artículo científico

Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas.

artículo científico publicado en 2009

SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).

artículo científico publicado en 2017

Sunitinib administered prior to radiotherapy in patients with non-resectable glioblastoma: results of a phase II study.

artículo científico publicado en 2014

Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study

scientific article published on 31 July 2019

Toxic epidermal necrolysis associated with interleukin-2

scientific article published on 01 July 2002

Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study

artículo científico publicado en 2013

VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer.

artículo científico publicado en 2013

[Burkitt's lymphoma in relation to acquired immunodeficiency syndrome (AIDS)]

artículo científico publicado en 1986

[Extragonadal germinal tumor syndrome]

scientific article published on 01 March 1986

Lista de obras de

A phase I study of irinotecan in combination with metronomic temozolomide in patients with recurrent glioblastoma

A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma.

ATCT-05OBJECTIVE RESPONSE (OR) TO NEOADJUVANT TREATMENT IN GLIOBLASTOMA AND ITS IMPACT ON OVERALL SURVIVAL (OS). A META-ANALYSIS OF NEOADJUVANT TRIALS OF THE SPANISH GROUP FOR RESEARCH IN NEUROONCOLOGY (GEINO).

Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial.

Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO).

Circulating Endothelial Cells and Microparticles as Prognostic Markers in Advanced Non-Small Cell Lung Cancer ⬇️

Circulating endothelial and endothelial progenitor cells in non-small-cell lung cancer.

Circulating endothelial cells and procoagulant microparticles in patients with glioblastoma: prognostic value.

Correction to: SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).

Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients.

Efficacy and tolerability of lacosamide for secondary epileptic seizures in patients with brain tumor: A multicenter, observational retrospective study

Erratum: Efficacy and tolerability of lacosamide for secondary epileptic seizures in patients with brain tumor: A multicenter, observational retrospective study.

Extended-schedule dose-dense temozolomide in refractory gliomas

Extragonadal germ cell tumors: prognostic factors and long-term follow-up

Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib

Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients

Long-term results of neoadjuvant chemotherapy and combined chemoradiotherapy before surgery in the management of locally advanced oesophageal cancer: a single-centre experience.

Neoadjuvant cisplatin and etoposide, with or without tamoxifen, prior to radiotherapy in high-grade gliomas: a single-center experience.

P17.04RANO CRITERIA APPLIED TO A PHASE II RANDOMIZED, MULTICENTER TRIAL COMPARING TEMOZOLOMIDE (TMZ) VS TMZ-PLUS-BEVACIZUMAB (BEV) BEFORE STANDARD TREATMENT IN UNRESECTABLE GLIOBLASTOMA (GBM) PATIENTS (P).GENOM 009 STUDY BY THE GEINO GROUP.

P18.08A MULTICENTRIC, OBSERVATIONAL, NON INTERVENTIONAL STUDY OF EFFICACY AND SAFETY OF LACOSAMIDE FOR THE TREATMENT OF EPILEPTIC SEIZURES IN PATIENTS WITH BRAIN TUMORS.

Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification

Phase II trial of irinotecan and metronomic temozolomide in patients with recurrent glioblastoma.

Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 patients

Primitive neuroectodermal kidney tumor

Radium-223 international early access program: results from the Spanish subset.

Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with renal cell carcinoma

Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas.

SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).

Sunitinib administered prior to radiotherapy in patients with non-resectable glioblastoma: results of a phase II study.

Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study

Toxic epidermal necrolysis associated with interleukin-2

Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study

VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer.

[Burkitt's lymphoma in relation to acquired immunodeficiency syndrome (AIDS)]

[Extragonadal germinal tumor syndrome]